Evaxion A/S (EVAX) Stock Forecast & Price Target

EVAX Forecast - Frequently Asked Questions

What is Evaxion A/S's forecast for 2025?

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Evaxion A/S is $11.00, with a high forecast of $16.00 and a low forecast of $6.00.

Should I buy or sell Evaxion A/S stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evaxion A/S in the last year. There is currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" EVAX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EVAX, but not buy additional shares or sell existing shares.

Does Evaxion A/S's stock price have much upside?

According to analysts, Evaxion A/S's stock has a predicted upside of 14.58% based on their 12-month stock forecasts.

What analysts cover Evaxion A/S?

Evaxion A/S has been rated by research analysts at HC Wainwright, and Weiss Ratings in the past 90 days.

Do Wall Street analysts like Evaxion A/S more than its competitors?

Analysts like Evaxion A/S more than other "medical" companies. The consensus rating score for Evaxion A/S is 2.33 while the average consensus rating score for "medical" companies is 2.33. Learn more on how EVAX compares to other companies.